Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1Ā 091,51
-2,30
-0,21%
ā€”1Ā 093,811Ā 096,521Ā 100,221Ā 091,51ā€”ā€”
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
ā€”608,77608,77612,97608,77ā€”ā€”
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1Ā 237,98
-16,83
-1,34%
ā€”1Ā 254,811Ā 253,011Ā 253,871Ā 226,33ā€”ā€”
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1Ā 744,71
-16,40
-0,93%
ā€”1Ā 761,111Ā 764,271Ā 766,881Ā 744,71ā€”ā€”
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
ā€”642,58644,87648,48640,18ā€”ā€”
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
ā€”851,13855,66858,75845,56ā€”ā€”
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
ā€”217,98217,98218,65216,88ā€”ā€”
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3Ā 260,69
+48,86
+1,52%
ā€”3Ā 211,833Ā 227,213Ā 268,383Ā 226,55ā€”ā€”
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
ā€”948,98948,58957,83941,97ā€”ā€”
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1Ā 466,80
-7,72
-0,52%
ā€”1Ā 474,521Ā 479,031Ā 481,041Ā 466,80ā€”ā€”
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2Ā 397,50
+5,38
+0,22%
ā€”2Ā 392,122Ā 396,952Ā 421,222Ā 382,32ā€”ā€”
Q1 2026 earnings ā€¢ released ā€¢ EPS beat +11,14% ā€¢ Revenue beat +5,24%
See results
BMY:NYSE
Bristol-Myers Squibb Co
58,22Ā USD
-3,91%
(-2,37) 1D
58,50Ā USD
+0,48% (+0,28)
After hours
Closed: 1-Š¼Š°Š¹, 16:00:04 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BMY...
Open
60,02Ā USD
High
60,08Ā USD
Low
58,03Ā USD
Mkt. cap
118,87Ā Š¼Š»Š“
Volume
18,37Ā Š¼Š»Š½
Dividend
4,33%
Quarterly dividend
0,63Ā USD
Ex dividend date
2026-Š¶., 2-яŠ½Š².
P/E ratio
16,34
52-wk high
62,89Ā USD
52-wk low
42,52Ā USD
EPS
3,56Ā USD
Beta
0,27
Shares outstanding
2,04Ā Š¼Š»Š“
No. of employees
32Ā Š¼ŠøŅ£
News stories
From sources across the web
Profile
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2024, 71% of the company's revenues came from the United States. The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
About Bristol-Myers Squibb Co
CEOChris Boerner
Employees32,5Ā Š¼ŠøŅ£
Founded1887
HeadquartersŠŃŒŃŽ-Š™Š¾Ń€Šŗ, ŠŃŒŃŽ Š™Š¾Ń€Šŗ, ŠŠ¼ŠµŃ€ŠøŠŗŠ° ŠšŠ¾ŃˆŠ¼Š¾ ŠØтŠ°Ń‚Ń‚Š°Ń€Ń‹
SectorPharmaceutical industry
Websitebms.com
Last report
2026-Š¶., 30-Š°Šæр.
Fiscal Period
Q1 2026
Normalized EPS / Estimate
1,58/ (1,42 est.)USD
+11,14%beat
Revenue / Estimate
11,49Ā Š¼Š»Š“/ (10,92Ā Š¼Š»Š“ est.)USD
+5,24%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-Š¶. ŠøюŠ½.
2025-Š¶. сŠµŠ½.
2025-Š¶. Š“ŠµŠŗ.
2026-Š¶. Š¼Š°Ń€.
Revenue
12,27Ā Š¼Š»Š“
12,22Ā Š¼Š»Š“
12,50Ā Š¼Š»Š“
11,49Ā Š¼Š»Š“
Cost of goods sold
3,36Ā Š¼Š»Š“
3,31Ā Š¼Š»Š“
3,51Ā Š¼Š»Š“
3,42Ā Š¼Š»Š“
Cost of revenue
3,36Ā Š¼Š»Š“
3,31Ā Š¼Š»Š“
3,51Ā Š¼Š»Š“
3,42Ā Š¼Š»Š“
Research and development expenses
2,26Ā Š¼Š»Š“
2,43Ā Š¼Š»Š“
2,56Ā Š¼Š»Š“
2,65Ā Š¼Š»Š“
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,69Ā Š¼Š»Š“
1,79Ā Š¼Š»Š“
2,09Ā Š¼Š»Š“
1,62Ā Š¼Š»Š“
Operating expense
4,78Ā Š¼Š»Š“
5,05Ā Š¼Š»Š“
5,47Ā Š¼Š»Š“
4,70Ā Š¼Š»Š“
Total operating expenses
8,14Ā Š¼Š»Š“
8,36Ā Š¼Š»Š“
8,98Ā Š¼Š»Š“
8,12Ā Š¼Š»Š“
Operating income
4,13Ā Š¼Š»Š“
3,86Ā Š¼Š»Š“
3,52Ā Š¼Š»Š“
3,36Ā Š¼Š»Š“
Other non operating income
399,00Ā Š¼Š»Š½
529,00Ā Š¼Š»Š½
544,00Ā Š¼Š»Š½
-32,00Ā Š¼Š»Š½
EBT including unusual items
1,77Ā Š¼Š»Š“
3,11Ā Š¼Š»Š“
1,47Ā Š¼Š»Š“
3,24Ā Š¼Š»Š“
EBT excluding unusual items
4,22Ā Š¼Š»Š“
4,07Ā Š¼Š»Š“
3,86Ā Š¼Š»Š“
3,33Ā Š¼Š»Š“
Income tax expense
460,00Ā Š¼Š»Š½
919,00Ā Š¼Š»Š½
384,00Ā Š¼Š»Š½
561,00Ā Š¼Š»Š½
Effective tax rate
25,96%
29,51%
26,12%
17,32%
Other operating expenses
-
-
-
-
Net income
1,31Ā Š¼Š»Š“
2,20Ā Š¼Š»Š“
1,09Ā Š¼Š»Š“
2,68Ā Š¼Š»Š“
Net profit margin
10,68%
18,01%
8,69%
23,30%
Earnings per share
1,46
1,63
1,26
1,58
Interest and investment income
139,00Ā Š¼Š»Š½
161,00Ā Š¼Š»Š½
148,00Ā Š¼Š»Š½
-
Interest expense
-485,00Ā Š¼Š»Š½
-482,00Ā Š¼Š»Š½
-432,00Ā Š¼Š»Š½
-
Net interest expenses
-346,00Ā Š¼Š»Š½
-321,00Ā Š¼Š»Š½
-284,00Ā Š¼Š»Š½
-
Depreciation and amortization charges
-
-
-
-
EBITDA
5,12Ā Š¼Š»Š“
4,91Ā Š¼Š»Š“
4,54Ā Š¼Š»Š“
3,96Ā Š¼Š»Š“
Gain or loss from assets sale
-7,00Ā Š¼Š»Š½
-9,00Ā Š¼Š»Š½
-
-34,00Ā Š¼Š»Š½
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer